Look-alike drugs are medications that can be confused with one another because of similar packaging, labeling, pill appearance, or drug names. In healthcare, they’re known as LASA medications (look-alike, sound-alike), and they account for an estimated 6 to 15% of all medication errors. The confusion can happen between two completely different drugs or even between different strengths of the same drug.
Why These Mix-Ups Happen
The core problem is straightforward: thousands of medications exist, and many of them share visual or linguistic similarities that make it easy to grab the wrong one. A pharmacist filling 200 prescriptions in a shift might reach for a box of one drug and accidentally pull a nearly identical box of another. A nurse in a dimly lit medication room might misread a label. A doctor’s handwritten prescription might turn one drug name into something that looks like another.
Several specific factors feed into the problem. Drug names that differ by only a few letters create confusion in both written and spoken orders. Packaging from the same manufacturer often uses identical layouts, fonts, and color schemes across different products, making two very different medications look like twins on a shelf. Vague verbal orders (“give half an ampule”) add ambiguity. And as new drugs hit the market at an accelerating pace, the pool of similar-sounding names keeps growing.
Distractions during dispensing are a major contributor. High workload, interruptions, and time pressure all reduce the attention a pharmacist or nurse can give to verifying each label. When someone is relying on visual recognition or shelf location rather than carefully reading the label, the odds of a mix-up climb.
Common Drug Pairs That Get Confused
Some of the most well-known examples involve drugs whose names differ by just a syllable or two. Vinblastine and vincristine are both cancer drugs, but they have very different uses and toxicity profiles. Cisplatin and carboplatin, also chemotherapy agents, are another pair. Outside of oncology, bupropion (an antidepressant) and buspirone (an anxiety medication) are frequently confused. Chlorpromazine (an antipsychotic) and chlorpropamide (a diabetes drug) share almost identical spelling. Clomiphene, a fertility drug, and clomipramine, an antidepressant, are another classic pair.
The confusion isn’t limited to similar names. In pharmacy dispensing data, pairs like Concor and Cozaar, or calcium acetate and calcium citrate, show up as common swap errors. Even drugs with quite different names can be confused if their boxes look alike on the shelf, particularly when they come from the same manufacturer and share identical packaging templates with only small text differences.
How Tall Man Lettering Works
One of the most widely adopted solutions is a simple typographic trick called Tall Man lettering. It capitalizes the letters that distinguish one drug name from another, making the differences jump out visually. For example, vinBLAStine versus vinCRIStine, or buPROPion versus busPIRone. The technique starts from the left side of the drug name and highlights where the two names diverge.
The FDA maintains an official list of drug name pairs that should use Tall Man lettering, and the Institute for Safe Medication Practices publishes its own expanded list. You’ll see this convention on pharmacy labels, hospital computer systems, and automated dispensing machines. It’s not a perfect fix on its own, but it forces the reader’s eye to the part of the name that matters most.
Color Coding and Packaging Strategies
Color plays a surprisingly complex role in medication safety. Manufacturers use color branding to distinguish products within the same drug class, and healthcare systems use standardized color schemes for certain high-risk categories. Red packaging and labeling, for instance, is recommended for neuromuscular blocking agents, which can cause paralysis if given in error. Black caps are the standard for concentrated potassium chloride. The American Academy of Ophthalmology has pushed for uniform color-coded caps on all topical eye medications. Purple marks oral syringes, and yellow-striped tubing is reserved exclusively for epidural lines to prevent them from being mistaken for regular IV tubing.
Color differentiation also shows up in subtler ways: red text on a manufacturer’s infusion bag signals that the solution contains an active medication, giving a quick visual cue beyond the fine print. But color can backfire, too. When a manufacturer uses the same color scheme across its entire product line to build brand recognition rather than to distinguish individual drugs, it actually increases the chance of picking errors.
How Hospitals and Pharmacies Prevent Errors
Most prevention strategies layer multiple safeguards rather than relying on any single fix. Physical separation is one of the simplest: hospitals store drugs with confusable names in different locations rather than alphabetically side by side. Some facilities assign bin numbers so that similar-sounding drugs end up on entirely different shelves or in separate drawers of automated dispensing cabinets.
Barcode scanning at the point of care is increasingly standard. Before a nurse administers a medication, the barcode on the drug package is scanned and matched against the patient’s electronic order. This closed-loop system catches errors that slip past human eyes, particularly when two packages look nearly identical. Hospitals also minimize verbal and telephone orders, since spoken drug names are even easier to confuse than written ones.
The World Health Organization recommends that medication orders include both the brand name and the generic (nonproprietary) name, with the generic name in a larger font. This redundancy gives an extra checkpoint. If a pharmacist sees that the brand name doesn’t match the generic name on the order, the mismatch is immediately visible. WHO guidelines also emphasize that healthcare workers should read the label every time they access a medication rather than relying on where the drug is stored or what the package looks like.
What This Means for Patients
You don’t need to memorize drug pair lists, but a few habits can protect you. When you pick up a prescription, check that the drug name, dose, and appearance match what you expect. If you’ve been taking a round white pill and the refill is suddenly an oval yellow one, ask the pharmacist whether the medication or manufacturer changed. This is especially important if you take multiple medications with similar-sounding names.
Knowing what your medication is for gives you another layer of protection. WHO guidelines specifically recommend that patients receive written information about each drug’s purpose, its generic and brand names, and its expected side effects. If a pharmacist hands you a medication and the stated purpose doesn’t match the condition you’re being treated for, that’s a signal to pause and verify. Hospitals are also encouraged to review dispensed medications directly with patients before administration, confirming that the drug’s appearance and indication match the prescription.
People with sight impairments, language barriers, or limited familiarity with the healthcare system face higher risk. If that applies to you or someone you care for, asking the pharmacist to walk through each medication at pickup, rather than just reading the label at home, can catch errors before they reach the medicine cabinet.